<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="decrease">
            <roleset id="decrease.02" name="" wordnet="1">
                <roles>
                    <role n="0" descr="theme&#x0A;" />
                    <role n="2" descr="amount decreased &#x09;&#x09;&#x09;&#x0A;" />
                    <role n="1" descr="location&#x0A;" />
                </roles>
                <example src="EGRAM" no="5c">
                    <text>Concomitantly, the levels of acetylcholine are able to decrease by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Concomitantly, the levels of acetylcholine can decrease by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="5e">
                    <text>Concomitantly, the levels of acetylcholine can have decreased by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="4b">
                    <text>Concomitantly, the levels of acetylcholine could decrease by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="1">37.8%</arg>
                    <arg n="2">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="0">
                    <text>Concomitantly, the levels of acetylcholine decrease by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>Concomitantly, the levels of acetylcholine decreased by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="1b">
                    <text>Concomitantly, the levels of acetylcholine have decreased by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="5bb">
                    <text>Concomitantly, the levels of acetylcholine may decrease by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="5f">
                    <text>Concomitantly, the levels of acetylcholine may have decreased by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="5bc">
                    <text>Concomitantly, the levels of acetylcholine might decrease by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="5cb">
                    <text>Concomitantly, the levels of acetylcholine were able to decrease by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>Concomitantly, the levels of acetylcholine were predicted to decrease by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>Concomitantly, the levels of acetylcholine were proven to decrease by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>Concomitantly, the levels of acetylcholine will decrease by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="5d">
                    <text>Concomitantly, the levels of acetylcholine will have decreased by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="5ba">
                    <text>Concomitantly, the levels of acetylcholine would decrease by 37.8% in the lead-treated animals as compared to the controls.</text>
                    <arg n="0">the levels of acetylcholine</arg>
                    <arg n="2">37.8%</arg>
                    <arg n="1">the lead-treated animals</arg>
                </example>
                <example src="EGRAM" no="*6c">
                    <text>Furthermore, the CD3? Expression has the ability to decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*6b">
                    <text>Furthermore, the CD3? Expression is proven to decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*6">
                    <text>Furthermore, the CD3? Expression was proven to decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*9">
                    <text>Furthermore, the CD3? expression can decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*9b">
                    <text>Furthermore, the CD3? expression can have decreased by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*9c">
                    <text>Furthermore, the CD3? expression could decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*7">
                    <text>Furthermore, the CD3? expression decreases by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*7b">
                    <text>Furthermore, the CD3? expression has decreased by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*10c">
                    <text>Furthermore, the CD3? expression is able to decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*8b">
                    <text>Furthermore, the CD3? expression is found to decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*10a">
                    <text>Furthermore, the CD3? expression may decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*10ab">
                    <text>Furthermore, the CD3? expression may have decreased by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*10ac">
                    <text>Furthermore, the CD3? expression might decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*10cb">
                    <text>Furthermore, the CD3? expression was able to decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*8">
                    <text>Furthermore, the CD3? expression was found to decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*10b">
                    <text>Furthermore, the CD3? expression will decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*10ba">
                    <text>Furthermore, the CD3? expression will have decreased by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="*10bb">
                    <text>Furthermore, the CD3? expression would decrease by mixing normal T cells with TBM-M?s in a cell-number-dependent manner (Fig.2B).</text>
                    <arg n="0">the CD3? expression</arg>
                </example>
                <example src="EGRAM" no="16i">
                    <text>In contrast, GP can have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>In contrast, GP can only decrease by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/- 3.9%</arg>
                    <arg n="2">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="16e">
                    <text>In contrast, GP could only decrease by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="11b">
                    <text>In contrast, GP has only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="16c">
                    <text>In contrast, GP is able to only decrease by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="12b">
                    <text>In contrast, GP is found to only decrease by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="13b">
                    <text>In contrast, GP is predicted to only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="14b">
                    <text>In contrast, GP is proven to only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/- 3.9%</arg>
                    <arg n="2">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="16h">
                    <text>In contrast, GP may have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="16b">
                    <text>In contrast, GP may only decrease by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="16f">
                    <text>In contrast, GP might only decrease by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>In contrast, GP only decreases by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>In contrast, GP was found to only decrease by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>In contrast, GP was predicted to only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>In contrast, GP was proven to only decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="1">12.4% +/- 3.9%</arg>
                    <arg n="2">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="16g">
                    <text>In contrast, GP will have decreased by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>In contrast, GP will only decrease by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
                <example src="EGRAM" no="16d">
                    <text>In contrast, GP would only decrease by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those having little to no increase in plasma citrulline concentration.</text>
                    <arg n="0">GP</arg>
                    <arg n="2">12.4% +/- 3.9%</arg>
                    <arg n="1">in those having little to no increase in plasma citrulline concentration</arg>
                    <arg n="M-ADV">only</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
